{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:49Z","timestamp":1792794709633,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.nmni.2019.100627","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T17:59:49Z","timestamp":1576000789000},"page":"100627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Antimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases"],"prefix":"10.1016","volume":"34","author":[{"given":"H.","family":"Madanchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shoushtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.H.","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sardari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.nmni.2019.100627_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/eog.11.63","article-title":"Vaginal innate immunity: alteration during pregnancy and its impact on pregnancy outcomes","volume":"6","author":"Mendez-Figueroa","year":"2011","journal-title":"Exp Rev Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1745-7262.2008.00367.x","article-title":"Global epidemiology of sexually transmitted diseases","volume":"10","author":"Da Ros","year":"2008","journal-title":"Asian J Androl"},{"issue":"7","key":"10.1016\/j.nmni.2019.100627_bib3","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","article-title":"Dengue viruses and promising envelope protein domain III-based vaccines","volume":"102","author":"Fahimi","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.nmni.2019.100627_bib4","first-page":"1265","article-title":"Rational development of antimicrobial peptides for therapeutic use: design and production of highly active compounds","author":"Maccari","year":"2013","journal-title":"Microb Pathog Strat Combat: Sci Technol Educ"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib5","article-title":"Synergism effect of nisin peptide in reducing chemical preservatives in food industry","volume":"9","author":"Kashani","year":"2012","journal-title":"Life Sci J"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/ph8010123","article-title":"Antimicrobial peptides in 2014","volume":"8","author":"Wang","year":"2015","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.nmni.2019.100627_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001067","article-title":"Antimicrobial peptides: primeval molecules or future drugs?","volume":"6","author":"Peters","year":"2010","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.nmni.2019.100627_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fcimb.2017.00290","article-title":"A novel chimeric endolysin with antibacterial activity against methicillin-resistant Staphylococcus aureus","volume":"7","author":"Haddad Kashani","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.nmni.2019.100627_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.phrp.2015.08.001","article-title":"Expression of recombinant pET22b-LysK-cysteine\/histidine-dependent amidohydrolase\/peptidase bacteriophage therapeutic protein in Escherichia coli BL21 (DE3)","volume":"6","author":"Kashani","year":"2015","journal-title":"Osong Public Health Res Perspect"},{"issue":"4","key":"10.1016\/j.nmni.2019.100627_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12602-016-9236-8","article-title":"Purification of antibacterial CHAP K protein using a self-cleaving fusion tag and its activity against methicillin-resistant Staphylococcus aureus","volume":"8","author":"Hosseini","year":"2016","journal-title":"Probiot Antimicrob Proteins"},{"issue":"3","key":"10.1016\/j.nmni.2019.100627_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI21948","article-title":"Dual role of \u03b1-defensin-1 in anti\u2013HIV-1 innate immunity","volume":"115","author":"Chang","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0897.2007.00561.x","article-title":"Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense","volume":"59","author":"Cole","year":"2008","journal-title":"Am J Reprod Immunol"},{"issue":"9","key":"10.1016\/j.nmni.2019.100627_bib13","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/CVI.00386-06","article-title":"Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection","volume":"14","author":"Novak","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"16","key":"10.1016\/j.nmni.2019.100627_bib14","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1097\/00002030-200311070-00001","article-title":"Human epithelial \u03b2-defensins 2 and 3 inhibit HIV-1 replication","volume":"17","author":"Qui\u00f1ones-Mateu","year":"2003","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.nmni.2019.100627_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1600-051X.2004.00594.x","article-title":"Myeloid-related protein (MRP) 8\/14 (calprotectin) and its subunits MRP8 and MRP14 in plaque-induced early gingival inflammation","volume":"31","author":"Que","year":"2004","journal-title":"J Clin Periodontol"},{"issue":"13","key":"10.1016\/j.nmni.2019.100627_bib16","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/QAD.0b013e32832ea643","article-title":"Elevated elafin\/trappin-2 in the female genital tract is associated with protection against HIV acquisition","volume":"23","author":"Iqbal","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.nmni.2019.100627_bib17","first-page":"93","article-title":"Natural antimicrobial peptides as promising anti-HIV candidates","volume":"13","author":"Wang","year":"2012","journal-title":"Curr Top Pept Protein Res"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.chom.2012.12.002","article-title":"Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells","volume":"13","author":"Ogawa","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.nmni.2019.100627_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.peptides.2015.05.004","article-title":"Inhibition of HIV infection by caerin 1 antimicrobial peptides","volume":"71","author":"VanCompernolle","year":"2015","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2009.12.004","article-title":"Antimicrobial peptides: general overview and clinical implications in human health and disease","volume":"135","author":"Guan\u00ed-Guerra","year":"2010","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.nmni.2019.100627_bib21","first-page":"523","article-title":"Correlation between Epstein-Barr virus infection and disease activity of systemic lupus erythematosus: a cross-sectional study","volume":"18","author":"Piroozmand","year":"2017","journal-title":"Asian Pac J Cancer Prevent: APJCP"},{"key":"10.1016\/j.nmni.2019.100627_bib22","series-title":"Immune-Mediated Diseases","first-page":"369","article-title":"Herpes simplex virus: treatment with antimicrobial peptides","author":"Kovalchuk","year":"2007"},{"issue":"8","key":"10.1016\/j.nmni.2019.100627_bib23","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1128\/AAC.48.8.3182-3184.2004","article-title":"A lipid-peptide microbicide inactivates herpes simplex virus","volume":"48","author":"Isaacs","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.nmni.2019.100627_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0074-02762007005000028","article-title":"In vitro antiviral activity of antimicrobial peptides against herpes simplex virus 1, adenovirus, and rotavirus","volume":"102","author":"Carriel-Gomes","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.nmni.2019.100627_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.antiviral.2007.03.012","article-title":"The anti-papillomavirus activity of human and bovine lactoferricin","volume":"75","author":"Mistry","year":"2007","journal-title":"Antiviral Res"},{"issue":"23","key":"10.1016\/j.nmni.2019.100627_bib26","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1021\/bi049552a","article-title":"Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus","volume":"43","author":"Liu","year":"2004","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.nmni.2019.100627_bib27","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1590\/0074-0276140220","article-title":"DEFB1 polymorphisms are involved in susceptibility to human papillomavirus infection in Brazilian gynaecological patients","volume":"109","author":"Segat","year":"2014","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.nmni.2019.100627_bib28","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1073\/pnas.0508033103","article-title":"Human \u03b1-defensins block papillomavirus infection","volume":"103","author":"Buck","year":"2006","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.nmni.2019.100627_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/infdis\/jir079","article-title":"Induction of human \u03b2-defensins and psoriasin in vulvovaginal human papillomavirus\u2013associated lesions","volume":"204","author":"Erhart","year":"2011","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.nmni.2019.100627_bib30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1462-5822.2005.00530.x","article-title":"Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37","volume":"7","author":"Bergman","year":"2005","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.nmni.2019.100627_bib31","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.3389\/fmicb.2018.02688","article-title":"The MtrCDE efflux pump contributes to survival of Neisseria gonorrhoeae from human neutrophils and their antimicrobial components","volume":"9","author":"Handing","year":"2018","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.nmni.2019.100627_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.diagmicrobio.2006.11.006","article-title":"Susceptibility of Neisseria gonorrhoeae to antimicrobial peptides from amphibian skin, dermaseptin, and derivatives","volume":"57","author":"Zairi","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.nmni.2019.100627_bib33","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/AAC.49.3.1201-1202.2005","article-title":"Activity of cathelicidin peptides against Chlamydia spp","volume":"49","author":"Donati","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.nmni.2019.100627_bib34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.micinf.2015.02.005","article-title":"Chlamydia-secreted protease CPAF degrades host antimicrobial peptides","volume":"17","author":"Tang","year":"2015","journal-title":"Microb Infect"},{"issue":"6","key":"10.1016\/j.nmni.2019.100627_bib35","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jac\/dkf220","article-title":"Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum","volume":"50","author":"Sambri","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.nmni.2019.100627_bib36","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/iai.59.4.1359-1367.1991","article-title":"Antimicrobial activity of rabbit leukocyte defensins against Treponema pallidum subsp. pallidum","volume":"59","author":"Borenstein","year":"1991","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.nmni.2019.100627_bib37","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.peptides.2003.07.026","article-title":"Susceptibility of Treponema pallidum to host-derived antimicrobial peptides","volume":"24","author":"Cox","year":"2003","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/dkn436","article-title":"The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis","volume":"63","author":"Park","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12879-016-1674-0","article-title":"Combination with antimicrobial peptide lyses improves loop-mediated isothermal amplification based method for Chlamydia trachomatis detection directly in urine sample","volume":"16","author":"Jevtu\u0161evskaja","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.nmni.2019.100627_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00203-012-0863-5","article-title":"Antimicrobial peptide from spider venom inhibits Chlamydia trachomatis infection at an early stage","volume":"195","author":"Lazarev","year":"2013","journal-title":"Arch Microbiol"},{"issue":"1 Supplement","key":"10.1016\/j.nmni.2019.100627_bib41","first-page":"65","article-title":"Increased expression of antimicrobial peptides in the cervix during Trichomonas vaginalis infection (MUC2P. 923)","volume":"194","author":"Makinde","year":"2015","journal-title":"Am Assoc Immnol"},{"key":"10.1016\/j.nmni.2019.100627_bib42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.peptides.2018.12.004","article-title":"Epinecidin-1: a marine fish antimicrobial peptide with therapeutic potential against trichomonas vaginalis infection in mice","volume":"112","author":"Huang","year":"2019","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40360-019-0309-7","article-title":"Epinecidin-1, a highly potent marine antimicrobial peptide with anticancer and immunomodulatory activities","volume":"20","author":"Neshani","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00284-010-9709-z","article-title":"Effect of the antimicrobial peptide tritrpticin on the in vitro viability and growth of trichomonas vaginalis","volume":"62","author":"Infante","year":"2011","journal-title":"Curr Microbiol"},{"issue":"7","key":"10.1016\/j.nmni.2019.100627_bib45","doi-asserted-by":"crossref","first-page":"e3175","DOI":"10.1002\/psc.3175","article-title":"AurH1: a new heptapeptide derived from Aurein1. 2 antimicrobial peptide with specific and exclusive fungicidal activity","volume":"25","author":"Madanchi","year":"2019","journal-title":"J Pept Sci"},{"issue":"3","key":"10.1016\/j.nmni.2019.100627_bib46","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-101-3-390","article-title":"Vulvovaginal candidiasis\u2014what we do and do not know","volume":"101","author":"Sobel","year":"1984","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.nmni.2019.100627_bib47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/deu018","article-title":"Antimicrobial host defence peptide, LL-37, as a potential vaginal contraceptive","volume":"29","author":"Srakaew","year":"2014","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ph9010013","article-title":"Potential use of antimicrobial peptides as vaginal spermicides\/microbicides","volume":"9","author":"Tanphaichitr","year":"2016","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: form follows function","volume":"11","author":"Fjell","year":"2012","journal-title":"Nat Rev Drug Disc"},{"issue":"1","key":"10.1016\/j.nmni.2019.100627_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2007.10.013","article-title":"Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3","volume":"29","author":"Maisetta","year":"2008","journal-title":"Peptides"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297519301246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297519301246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:57:59Z","timestamp":1761854279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297519301246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":50,"alternative-id":["S2052297519301246"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2019.100627","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2019.100627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100627"}}